Additional information
White Powder
1159977-36-2
ACI-025802
168.8-170.1°C
C18H14F4N2O4S
430.37
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(2RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
N-[4-Cyano-3-trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
2-Fluoro-4-Desfluoro Bicalutamide





![LINAGLIPTIN DIMER (25 mg) (N¹,N²-Bis{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-{(4-methylquinazolin-2-yl)methyl}-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}phthalamide)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)